Mid-range arc therapy for efficient and RBE-robust proton treatment.

Qingying Wang1, Mingli Chen1, Yinheng Zhu1

  • 1Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.

Summary

Mid-Range Proton Arc Therapy (MRPAT) offers an efficient solution for proton arc therapy, improving delivery speed and containing biological uncertainties within the target. This novel approach enhances normal tissue sparing and is practical for clinical implementation.